Search
Close this search box.

Get our email updates

Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.

Advertisement
Advertisement

Lotte Biologics begins operations in Bristol Myers Squibb’s DeWitt facility

South Korean firm Lotte Biologics has acquired the DeWitt manufacturing facility of Bristol Myers Squibb in a transaction that closed Dec. 31. Bristol Myers Squibb is a global pharmaceutical company based in New Jersey. (FILE PHOTO CREDIT: ZOEYADVERTISING.COM)

DeWITT, N.Y. — The facility at 6000 Thompson Road in DeWitt that for many years housed manufacturing operations for Bristol Myers Squibb Co. (NYSE: BMY) is now under new ownership. Bristol Myers Squibb on Jan. 3 announced it had completed the sale of the property to Lotte Biologics of Seoul, South Korea. It sold the […]

Already an Subcriber? Log in

Get Instant Access to This Article

Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.

Post
Share
Tweet
Print
Email

Get our email updates

Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.

Essential business news, thoughtful analysis and valuable insights for Central New York business leaders.

Copyright © 2023 Central New York Business Journal. All Rights Reserved.